Life Sciences & Medtech Payment Performance: A Minor Uptick of 1 Point in 2024

The Comparison

• 2023: An analysis of 118 companies within the life sciences and medical technology sectors yielded an average payment performance score of 59.8 out of 100.
• 2024: A slightly smaller sample size of 113 companies showed a marginal increase, achieving an average score of 60.8 out of 100.

What This Means

The one-point increase suggests a nearly static payment environment in life sciences and medtech; while technically positive, the change is so small that factors such as sample selection are likely to be influential. Suppliers looking to improve cash flow should use a late payment calculator to see the impacts of late payments.

One-line summary: Payment performance in Life Sciences & Medtech improved from 59.8 (118 companies) in 2023 to 60.8 (113 companies) in 2024.